Members Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$906K Buy
762
+21
+3% +$24.8K 0.45% 43
2026
Q2
$889K Buy
741
+13
+2% +$13.3K 0.49% 42
2026
Q1
$670K Sell
728
-21
-3% -$21.3K 0.4% 43
2025
Q4
$796K Sell
749
-69
-8% -$66K 0.5% 39
2025
Q3
$676K Buy
+818
New +$609K 0.43% 47
2025
Q1
$696K Buy
843
+23
+3% +$19.1K 0.53% 46
2024
Q4
$716K Buy
+820
New +$679K 0.53% 43
2024
Q2
$679K Buy
+873
New +$698K 0.46% 44

Other funds holding LLY

Members Wealth's LLY Position: Q3 2026 in Review

Members Wealth increased its Eli Lilly (LLY) stake by 2.8% in Q3 2026, buying an estimated $24.8K and bringing the position to 762 shares worth $906K. The position accounts for 0.45% of the portfolio, ranked #43.

Members Wealth first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. 2,091 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Members Wealth held 762 shares of Eli Lilly worth $906K as of Q3 2026.
  • Members Wealth bought 21 Eli Lilly shares in Q3 2026, an estimated $24.8K.
  • Eli Lilly made up 0.45% of Members Wealth's portfolio in Q3 2026, its #43 holding.
  • Members Wealth first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • 2,091 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Members Wealth's 13F filing for Q3 2026, filed 20 Oct 2026.